Mobility & Transportation

Revelstoke Capital Partners is a Denver-based private equity firm focused on building industry-leading companies in the healthcare and related business services sectors. The firm partners with entrepreneurs and management teams to execute a disciplined organic and acquisition growth strategy, aiming to build exceptional companies. Since its inception in 2013, Revelstoke has raised over $2.3 billion in equity and completed 65 acquisitions, including 17 platform companies and 48 add-on acquisitions.

Bessemer Venture Partners is a leading venture capital firm that partners with entrepreneurs from their early days through every stage of growth. With a history rooted in the Carnegie Steel empire, Bessemer has a long tradition of investing in transformative companies across various industries. The firm is committed to supporting entrepreneurs with capital, strategic guidance, and a robust network to build enduring companies.

Established in 1996, VantagePoint Capital Partners is a global venture investor with a focus on energy innovation and efficiency. With over $4 billion under management, the firm supports companies from start-up to scale-up, providing not only capital but also strategic resources, partnership alliances, and ongoing support. Headquartered in Silicon Valley, VantagePoint has offices in Beijing and strategic partners worldwide, emphasizing its commitment to energy innovation and efficiency.

Pittsburgh Life Sciences Greenhouse (PLSG) is a leading life sciences investment firm in Western Pennsylvania, dedicated to fostering innovation and commercialization in the life sciences sector. PLSG supports entrepreneurs and emerging companies by providing funding, strategic guidance, and access to resources, with a focus on improving healthcare outcomes and driving economic growth in the region. The firm is deeply connected to the growing impact of data analytics in healthcare and is committed to supporting underserved groups through initiatives like the 'Under 40, Underserved Advisory Board'.

SV Health Investors is a leading venture capital firm focused on investing in innovative healthcare companies. With a mission to transform healthcare one investment at a time, SV Health Investors supports diverse entrepreneurs in creating breakthrough companies and treatments. The firm has a strong track record of investing in companies that improve healthcare through innovative care delivery models, next-generation digital health technologies, and groundbreaking medical products. SV Health Investors is committed to diversity and believes that it strongly contributes to success.

KKR is a leading global investment firm founded in 1976, known for its pioneering role in the private equity industry. The firm is committed to delivering strong returns and shared success to its clients and the world at large. KKR invests across various asset classes, including private equity, infrastructure, real estate, and credit, with a focus on fortifying companies and communities. The firm emphasizes a culture of shared ownership and long-term value creation, aligning its interests with those of its investors and portfolio companies.

Glynn Capital is a private and public technology investment firm focused on long-term investments in technology growth companies. The firm aims to partner with exceptional teams leveraging disruptive technologies to address markets ripe for change. Glynn Capital invests in both private early-growth stage companies and public durable growth companies, seeking to add value through experience and networks.

City Side Ventures is a dynamic venture group established in 2015, focused on transforming early-stage capital deployment in Michigan. The firm is driven by experienced business builders, serial entrepreneurs, and technologists, aiming to elevate Michigan's startup ecosystem by building a network of innovative investors. City Side Ventures emphasizes investing in the 'driver' (the founder) rather than the 'car' (the business), and is committed to integrity, courage, impact, responsibility, and velocity in its operations.

SR One is a biotechnology venture capital firm that partners with founders and entrepreneurs to translate innovative science into medicines. With a transatlantic presence, SR One focuses on companies with strong fundamentals and novel approaches to addressing diseases, aiming to reimagine today's science for tomorrow's medicines.

GV, originally launched as Google Ventures in 2009, is a venture capital firm that operates independently with Alphabet as its sole limited partner. The firm focuses on supporting innovative founders at every stage of company-building, leveraging its access to Google's resources and expertise. With over $10 billion in assets under management, GV invests in a diverse range of industries, including technology, healthcare, and consumer products, and supports over 400 active portfolio companies across North America, Europe, and Israel.

SoftBank Vision Fund is a leading venture capital firm that believes in the transformative power of technology. The firm focuses on supporting a full-stack AI technology ecosystem, investing in hardware, infrastructure, and applications to drive innovation across various sectors. With a mission to back ambitious founders with scalable visions, SoftBank Vision Fund aims to create meaningful impact through long-term investments.

NewSpring Capital is a private equity firm that partners with lower-middle market companies to create measurable value for business owners and Limited Partners. With over 25 years of experience, NewSpring focuses on fostering deep and enduring relationships, aligning goals and values with entrepreneurs, investors, and employees in pursuit of excellence. The firm manages over $3.5 billion across five distinct strategies, including growth equity, healthcare, mezzanine debt, holdings, and franchise investments. NewSpring is committed to accelerating growth and success for its portfolio companies through tailored capital solutions and strategic support.

Lux Capital is a venture capital firm that turns science fiction into science fact. They are a team of big dreamers and deep thinkers dedicated to building a better tomorrow by investing in companies at the intersection of the new and the not-yet-imagined. Lux Capital looks decades into the future to create a world that most can barely imagine, championing companies that work on groundbreaking innovations.

Osage University Partners (OUP) is a venture capital firm that specializes in investing in startups emerging from university research. With a focus on deep technology and science-based startups, OUP partners with over 100 universities and research institutions globally. The firm manages approximately $800 million and is committed to supporting groundbreaking scientific innovations through strategic investments and partnerships. Since its inception in 2009, OUP’s mission has been to foster deep partnerships with universities to invest in their spinouts, improve technology transfer effectiveness, and enhance research commercialization by connecting university startups to funding and recruitment opportunities.

Presidio Partners is a venture capital firm that redefines venture investing and management by focusing on active portfolio management, transparency, teamwork, and accountability. With over 25 years of experience, the firm leverages its deep sector knowledge in life sciences, information technology, and energy technology to identify and maximize opportunities. Presidio Partners emphasizes a fresh approach to venture capital, driven by experience and a commitment to creating significant companies that can become game changers. The firm values transparency and collaboration, assigning two team members to every major investment to stimulate collaboration and accountability.

VTC Ventures is a venture capital firm that invests in early-stage life sciences and high-growth technology companies. It operates through two main investment vehicles: the VTC Innovation Fund, focusing on Series A and B rounds, and the VTC Seed Fund, targeting seed stage investments. Primarily funded by Virginia Tech and Carilion Clinic, VTC Ventures aims to create long-term value within the Virginia Tech and Carilion Clinic ecosystem, while also pursuing high-growth opportunities across Virginia, the Mid-Atlantic, and nationwide.